Literature DB >> 11951212

Hepatic artery chemoembolization.

Kevin L Sullivan1.   

Abstract

Chemoembolization is a technique that can deliver high concentrations of therapeutic agents directly to the liver for prolonged periods. Considerable experience has been gained in the treatment of hepatocellular carcinoma, where it appears to be a safe procedure that provides survival advantage over conservative therapy. There is much less experience in the treatment of hepatic metastases. Patients with carcinoid, pancreatic islet cell tumor, and sarcoma metastatic to the liver do appear to benefit from chemoembolization. Efficacy in other groups, such as patients with colorectal cancer metastatic to the liver, is less well established, but a recently initiated multicenter trial may resolve this issue. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11951212     DOI: 10.1053/sonc.2002.31671

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver.

Authors:  Avo Artinyan; Rebecca Nelson; Perry Soriano; Vincent Chung; Janet Retseck; Jonathon Reynolds; Howard Marx; Joseph Kim; Lawrence Wagman
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 2.  Metastasectomy for limited metastases from soft tissue sarcoma.

Authors:  Eddie K Abdalla; Peter W T Pisters
Journal:  Curr Treat Options Oncol       Date:  2002-12

Review 3.  Gastrointestinal stromal tumor and its targeted therapeutics.

Authors:  Jheri Dupart; Wei Zhang; Jonathan C Trent
Journal:  Chin J Cancer       Date:  2011-05

4.  Laparoscopic debridement of hepatic necrosis after hepatic artery chemoembolization.

Authors:  Talar Tejirian; Anthony Heaney; Stephen Colquhoun; Nicholas Nissen
Journal:  JSLS       Date:  2007 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.